|
a |
|
b/clusters/9knumclustersv2/clust_1163.txt |
|
|
1 |
INR > . |
|
|
2 |
INR < . (or < on anticoagulants) |
|
|
3 |
INR < . ULN |
|
|
4 |
INR ?. ULN |
|
|
5 |
INR ? . |
|
|
6 |
INR < . ULN |
|
|
7 |
INR ? . x ULN; |
|
|
8 |
INR ?. |
|
|
9 |
INR > |
|
|
10 |
INR >= |
|
|
11 |
INR and APTT ? . x ULN. |
|
|
12 |
INR > . |
|
|
13 |
INR =< . |
|
|
14 |
Low-dose Coumadin ( mg) is acceptable; however, doses that increase INR are not permitted; if an alternative to Coumadin-based anticoagulants cannot be used, the INR should be monitored weekly after initiation of therapy and upon discontinuation of INCB, until INR normalization |
|
|
15 |
Low-dose Coumadin ( mg) is acceptable; however, doses that increase INR are not permitted; if an alternative to Coumadin-based anticoagulants cannot be used, the INR should be monitored weekly after initiation of therapy and upon discontinuation of INCB, until INR normalization |
|
|
16 |
INR < . |
|
|
17 |
Coagulation INR less than or equal to . x ULN (or in range INR, usually between and , if a patient is on a stable dose of therapeutic warfarin). |
|
|
18 |
INR < . ULN |
|
|
19 |
INR and aPTT < . X ULN unless on medication known to alter INR and aPTT. |
|
|
20 |
INR . to ULN or ? for subjects receiving anticoagulant therapy |
|
|
21 |
INR < . ULN |
|
|
22 |
INR and aPTT within . ULN |
|
|
23 |
INR > . |
|
|
24 |
INR ? , |
|
|
25 |
INR > . (or > if on anticoagulant therapy) |
|
|
26 |
Most recent INR prior to surgery > . |